Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers-Reference-Cited by-同舟云学术

Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers

Published:2014-03 Issue:1 Volume:233 Page:219-223
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Besseling Joost,Kindt Iris,Hof Michel,Kastelein John J.P.,Hutten Barbara A.,Hovingh G. Kees

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Diagnosis and treatment of familial hypercholesterolaemia;Hovingh;Eur Heart J,2013

2. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia;Hill;Arterioscler Thromb Vasc Biol,1991

3. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation;Ferrières;Circulation,1995

4. Evaluation of the cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood;Cobbaert;Eur J Clin Chem Clin Biochem,1994

5. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge;Friedewald;Clin Chem,1972

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organosulfur Compounds, S‐Allyl‐L‐Cysteine and S‐Ethyl‐L‐Cysteine, Target PCSK‐9/LDL‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndrome in Rats;Phytotherapy Research;2024-09-03

2. Asymptomatic Intracranial Artery Stenosis/Occlusion in Heterozygous Familial Hypercholesterolemia: Its Frequency and Implications for Cerebrovascular and Cardiovascular Events;Journal of the American Heart Association;2024-08-06

3. Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome;Circulation: Cardiovascular Quality and Outcomes;2024-08

4. Biochemical and Anthropometric Outcomes in Paediatric Patients with Heterozygous Familial Hypercholesterolemia after COVID-19 Pandemic Lockdowns: An Exploratory Analysis;Nutrients;2024-07-08

5. Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis;European Heart Journal;2024-07-08